Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
    • Reprint Information
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Reprint Information
    • Subscriptions
    • Feedback
  • ASN Kidney News
  • Other
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
    • Reprint Information
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Reprint Information
    • Subscriptions
    • Feedback
  • ASN Kidney News
  • Visit ASN on Facebook
  • Follow CJASN on Twitter
  • CJASN RSS
  • Community Forum

myocardial infarction

  • Apixaban versus No Anticoagulation in Patients Undergoing Long-Term Dialysis with Incident Atrial Fibrillation
    You have accessRestricted Access
    Apixaban versus No Anticoagulation in Patients Undergoing Long-Term Dialysis with Incident Atrial Fibrillation
    Thomas A. Mavrakanas, Katherine Garlo and David M. Charytan
    CJASN August 2020, 15 (8) 1146-1154; DOI: https://doi.org/10.2215/CJN.11650919
    Add to Selected Citations
  • Association of Serum Uromodulin with Death, Cardiovascular Events, and Kidney Failure in CKD
    You have accessRestricted Access
    Association of Serum Uromodulin with Death, Cardiovascular Events, and Kidney Failure in CKD
    Dominik Steubl, Markus P. Schneider, Heike Meiselbach, Jennifer Nadal, Matthias C. Schmid, Turgay Saritas, Vera Krane, Claudia Sommerer, Seema Baid-Agrawal, Jakob Voelkl, Fruzsina Kotsis, Anna Köttgen, Kai-Uwe Eckardt, Jürgen E. Scherberich and GCKD Study Investigators
    CJASN May 2020, 15 (5) 616-624; DOI: https://doi.org/10.2215/CJN.11780919
    Add to Selected Citations
  • Cardiovascular Safety and All-Cause Mortality of Methoxy Polyethylene Glycol-Epoetin Beta and Other Erythropoiesis-Stimulating Agents in Anemia of CKD
    You have accessRestricted Access
    Cardiovascular Safety and All-Cause Mortality of Methoxy Polyethylene Glycol-Epoetin Beta and Other Erythropoiesis-Stimulating Agents in Anemia of CKD
    Francesco Locatelli, Thierry Hannedouche, Steven Fishbane, Zoe Morgan, Delphine Oguey and William B. White
    CJASN December 2019, 14 (12) 1701-1710; DOI: https://doi.org/10.2215/CJN.01380219
    Add to Selected Citations
  • Serum Calcification Propensity and Clinical Events in CKD
    You have accessRestricted Access
    Serum Calcification Propensity and Clinical Events in CKD
    Joshua D. Bundy, Xuan Cai, Rupal C. Mehta, Julia J. Scialla, Ian H. de Boer, Chi-yuan Hsu, Alan S. Go, Mirela A. Dobre, Jing Chen, Panduranga S. Rao, Mary B. Leonard, James P. Lash, Geoffrey A. Block, Raymond R. Townsend, Harold I. Feldman, Edward R. Smith, Andreas Pasch, Tamara Isakova and the CRIC Study Investigators
    CJASN November 2019, 14 (11) 1562-1571; DOI: https://doi.org/10.2215/CJN.04710419
    Add to Selected Citations
  • Association of Acute Increases in Plasma Creatinine after Renin-Angiotensin Blockade with Subsequent Outcomes
    You have accessRestricted Access
    Association of Acute Increases in Plasma Creatinine after Renin-Angiotensin Blockade with Subsequent Outcomes
    Edouard L. Fu, Marco Trevisan, Catherine M. Clase, Marie Evans, Bengt Lindholm, Joris I. Rotmans, Merel van Diepen, Friedo W. Dekker and Juan-Jesus Carrero
    CJASN September 2019, 14 (9) 1336-1345; DOI: https://doi.org/10.2215/CJN.03060319
    Add to Selected Citations
  • Combination of Changes in Estimated GFR and Albuminuria and the Risk of Major Clinical Outcomes
    You have accessRestricted Access
    Combination of Changes in Estimated GFR and Albuminuria and the Risk of Major Clinical Outcomes
    Toshiaki Ohkuma, Min Jun, John Chalmers, Mark E. Cooper, Pavel Hamet, Stephen Harrap, Sophia Zoungas, Vlado Perkovic, Mark Woodward and on behalf of the ADVANCE Collaborative Group
    CJASN June 2019, 14 (6) 862-872; DOI: https://doi.org/10.2215/CJN.13391118
    Add to Selected Citations
  • Duration of Dual Antiplatelet Therapy in Patients with CKD and Drug-Eluting Stents
    You have accessRestricted Access
    Duration of Dual Antiplatelet Therapy in Patients with CKD and Drug-Eluting Stents
    Thomas A. Mavrakanas, Yiannis S. Chatzizisis, Karim Gariani, Dean J. Kereiakes, Giuseppe Gargiulo, Gérard Helft, Martine Gilard, Fausto Feres, Ricardo A. Costa, Marie-Claude Morice, Jean-Louis Georges, Marco Valgimigli, Deepak L. Bhatt, Laura Mauri and David M. Charytan
    CJASN June 2019, 14 (6) 810-822; DOI: https://doi.org/10.2215/CJN.12901018
    Add to Selected Citations
  • Trimethylamine <em>N</em>-Oxide and Cardiovascular Outcomes in Patients with ESKD Receiving Maintenance Hemodialysis
    You have accessRestricted Access
    Trimethylamine N-Oxide and Cardiovascular Outcomes in Patients with ESKD Receiving Maintenance Hemodialysis
    Jason R. Stubbs, Margaret R. Stedman, Sai Liu, Jin Long, Yoko Franchetti, Raymond E. West, Alexander J. Prokopienko, Jonathan D. Mahnken, Glenn M. Chertow and Thomas D. Nolin
    CJASN February 2019, 14 (2) 261-267; DOI: https://doi.org/10.2215/CJN.06190518
    Add to Selected Citations
  • Open Access
    Mapping Progress in Reducing Cardiovascular Risk with Kidney Disease
    Tariq Shafi and Eliseo Guallar
    CJASN September 2018, 13 (9) 1429-1431; DOI: https://doi.org/10.2215/CJN.02760218
    Add to Selected Citations
  • Add-On Antihypertensive Medications to Angiotensin-Aldosterone System Blockers in Diabetes
    You have accessRestricted Access
    Add-On Antihypertensive Medications to Angiotensin-Aldosterone System Blockers in Diabetes
    Emily B. Schroeder, Michel Chonchol, Susan M. Shetterly, J. David Powers, John L. Adams, Julie A. Schmittdiel, Gregory A. Nichols, Patrick J. O’Connor and John F. Steiner
    CJASN May 2018, 13 (5) 727-734; DOI: https://doi.org/10.2215/CJN.09510817
    Add to Selected Citations

Pages

  • Next
  • 1
  • 2

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Trainee of the Year
  • Author Resources
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • CJASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About CJASN
  • CJASN Email Alerts
  • CJASN Key Impact Information
  • CJASN Podcasts
  • CJASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1555-9041 Online ISSN - 1555-905X

Powered by HighWire